Cargando…
Pharmacogenetics Approach for the Improvement of COVID-19 Treatment
The treatment of coronavirus disease 2019 (COVID-19) has been a challenge. The efficacy of several drugs has been evaluated and variability in drug response has been observed. Pharmacogenetics could explain this variation and improve patients’ outcomes with this complex disease; nevertheless, severa...
Autores principales: | Fricke-Galindo, Ingrid, Falfán-Valencia, Ramcés |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998786/ https://www.ncbi.nlm.nih.gov/pubmed/33807592 http://dx.doi.org/10.3390/v13030413 |
Ejemplares similares
-
Genetics Insight for COVID-19 Susceptibility and Severity: A Review
por: Fricke-Galindo, Ingrid, et al.
Publicado: (2021) -
The rs16969968 Tobacco Smoking-Related Single-Nucleotide Variant Is Associated with Clinical Markers in Patients with Severe COVID-19
por: Valencia-Pérez Rea, Daniela, et al.
Publicado: (2023) -
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
por: Franczyk, Beata, et al.
Publicado: (2022) -
Outcome predictors in COVID-19: An analysis of emergent systemic inflammation indices in Mexican population
por: Gutiérrez-Pérez, Ilse Adriana, et al.
Publicado: (2022) -
Th17 profile in COPD exacerbations
por: Ponce-Gallegos, Marco Antonio, et al.
Publicado: (2017)